Embolic Protection Devices Market: Embolic Protection Devices: Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.40% during 2022 to 2030

Pune, India, May 2023 /MRFR Press Release/- Market Research Future (MRFR) announces the publication of its research report – Global Embolic Protection Devices Market 2022–2030

Embolic Protection Devices Market Highlights

Global Embolic Protection Devices Market is expected to grow at a CAGR of 8.40% during the forecast period (2022-2030) and is projected to worth USD 558.03 Million by 2030.

Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures.

Regional Analysis

The Americas dominates the global embolic protection devices market owing to the increasing aging population, which eventually leads to the increasing patient population. Additionally, the increasing cardiovascular disorder rates are likely to enhance the growth of embolic protection devices in the North American region. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S.

Europe accounts for the second largest market due to the increasing cardiovascular disorders and increasing obesity rates. Additionally, the increasing government support and increasing healthcare infrastructure along with the rising demand for minimally invasive treatment are driving the growth of the embolic protection devices market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above. This rising older population is likely to lead to the increased patient population. These factors are likely to drive the growth of the embolic protection devices market.

Asia Pacific is the fastest growing market for the embolic protection devices whose growth is attributed to rising population and increasing standard of living. Additionally, increasing healthcare spending and rising demand for new and innovative treatment options are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.

On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Embolic Protection Devices Market Research Report

Segmentation

The global embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user.

On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.

On the basis of material, the market is segmented into nitinol and polyurethane.

On the basis of usage, the market is segmented into disposable devices and reusable devices. 

On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.

On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.

Key Players

Some of the key players in the Embolic Protection Devices market are Medtronic, Abbott, Boston Scientific, Cordis. Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.